Predictive Oncology Stock Price Prediction

POAI Stock  USD 0.78  0.02  2.50%   
As of 29th of November 2024, the relative strength index (RSI) of Predictive Oncology's share price is approaching 49 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Predictive Oncology, making its price go up or down.

Oversold Vs Overbought

49

 
Oversold
 
Overbought
The successful prediction of Predictive Oncology's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Predictive Oncology, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Predictive Oncology's stock price prediction:
Wall Street Target Price
3
Quarterly Revenue Growth
(0.43)
Using Predictive Oncology hype-based prediction, you can estimate the value of Predictive Oncology from the perspective of Predictive Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Predictive Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Predictive because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Predictive Oncology after-hype prediction price

    
  USD 0.79  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Predictive Oncology Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.
Intrinsic
Valuation
LowRealHigh
0.091.807.65
Details
Naive
Forecast
LowNextHigh
0.020.826.68
Details
1 Analysts
Consensus
LowTargetHigh
4.555.005.55
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Predictive Oncology. Your research has to be compared to or analyzed against Predictive Oncology's peers to derive any actionable benefits. When done correctly, Predictive Oncology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Predictive Oncology.

Predictive Oncology After-Hype Price Prediction Density Analysis

As far as predicting the price of Predictive Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Predictive Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Predictive Oncology, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Predictive Oncology Estimiated After-Hype Price Volatility

In the context of predicting Predictive Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Predictive Oncology's historical news coverage. Predictive Oncology's after-hype downside and upside margins for the prediction period are 0.04 and 6.64, respectively. We have considered Predictive Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.78
0.79
After-hype Price
6.64
Upside
Predictive Oncology is dangerous at this time. Analysis and calculation of next after-hype price of Predictive Oncology is based on 3 months time horizon.

Predictive Oncology Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Predictive Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Predictive Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Predictive Oncology, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.11 
5.85
  0.01 
  0.06 
4 Events / Month
11 Events / Month
In about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.78
0.79
1.28 
8,357  
Notes

Predictive Oncology Hype Timeline

Predictive Oncology is at this time traded for 0.78. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.06. Predictive is forecasted to increase in value after the next headline, with the price projected to jump to 0.79 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 1.28%, whereas the daily expected return is at this time at -0.11%. The volatility of related hype on Predictive Oncology is about 1084.77%, with the expected price after the next announcement by competition of 0.84. The company reported the previous year's revenue of 1.78 M. Net Loss for the year was (13.98 M) with profit before overhead, payroll, taxes, and interest of 1 M. Given the investment horizon of 90 days the next forecasted press release will be in about 4 days.
Check out Predictive Oncology Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.

Predictive Oncology Related Hype Analysis

Having access to credible news sources related to Predictive Oncology's direct competition is more important than ever and may enhance your ability to predict Predictive Oncology's future price movements. Getting to know how Predictive Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Predictive Oncology may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
GCTKGlucoTrack(0.06)6 per month 0.00 (0.20) 10.40 (13.89) 90.86 
GMVDG Medical Innovations 0.01 1 per month 0.00 (0.15) 5.26 (9.09) 36.17 
STSSSharps Technology 0.22 7 per month 0.00 (0.06) 9.29 (10.13) 34.02 
MBOTMicrobot Medical(0.08)5 per month 2.33 (0.03) 5.38 (4.60) 15.87 
NXGLNexgel Inc 0.05 6 per month 3.20  0.06  8.02 (5.63) 28.75 
PDEXPro Dex(2.14)8 per month 4.44  0.24  10.44 (9.00) 30.21 
LUCYInnovative Eyewear(1.71)6 per month 5.89  0.12  25.00 (10.45) 69.90 
ZJYLJIN MEDICAL INTERNATIONAL(0.12)5 per month 0.00 (0.15) 8.49 (11.20) 78.47 
BNGOBionano Genomics(0.05)8 per month 0.00 (0.22) 9.09 (7.14) 24.71 
ISRGIntuitive Surgical 11.25 11 per month 1.01  0.03  2.03 (1.89) 12.08 
STXSStereotaxis(0.02)7 per month 3.01 (0.03) 4.19 (5.64) 27.16 
NYXHNyxoah 0.06 7 per month 2.10 (0.02) 5.40 (3.60) 11.03 
DXRDaxor 0.07 4 per month 3.89  0.03  5.40 (6.76) 34.14 
MLSSMilestone Scientific 0.07 10 per month 3.64  0.01  9.68 (7.89) 27.59 

Predictive Oncology Additional Predictive Modules

Most predictive techniques to examine Predictive price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Predictive using various technical indicators. When you analyze Predictive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Predictive Oncology Predictive Indicators

The successful prediction of Predictive Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Predictive Oncology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Predictive Oncology based on analysis of Predictive Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Predictive Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Predictive Oncology's related companies.
 2021 2022 2024 (projected)
Payables Turnover0.480.540.31
Days Of Inventory On Hand290.55311.08387.01

Story Coverage note for Predictive Oncology

The number of cover stories for Predictive Oncology depends on current market conditions and Predictive Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Predictive Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Predictive Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Predictive Oncology Short Properties

Predictive Oncology's future price predictability will typically decrease when Predictive Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Predictive Oncology often depends not only on the future outlook of the potential Predictive Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Predictive Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares OutstandingM
Cash And Short Term Investments8.7 M

Complementary Tools for Predictive Stock analysis

When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
FinTech Suite
Use AI to screen and filter profitable investment opportunities